Sonoma PharmaceuticalsSNOA
13F holders, Q1 2025 (March 31)12holders +3
3new positions
0sold out
$2.16avg. 13F price*
At the end of Q1 2025, 12 institutions reported holding Sonoma Pharmaceuticals Inc. (SNOA) in their 13F filings, up 3 from Q4 2024. 3 opened new positions and 0 sold out. The largest holders were Geode Capital Management, LLC ($37K), HRT Financial LP ($25K) and UBS Group AG ($4K).
- Company
- Sonoma Pharmaceuticals Inc.
- CUSIP
- 83558L303
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $64K |
| Exits | 0 | $0 |
All 13F filers, Q4 2024 → Q1 2025: 29,462 shares bought and 16,538 shares sold, net +12,924 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 12 holders
| Geode Capital Management, LLC | 0.00% | New | 16,805 | $37K |
| HRT Financial LP | 0.00% | New | 11,843 | $25K |
| UBS Group AG | 0.00% | Reduce -89.4% | 1,852 | $4K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -39.9% | 1,447 | $3K |
| Citigroup Inc. | 0.00% | New | 811 | $2K |
| JPMorgan Chase & Co. | 0.00% | No change | 138 | $302 |
| BlackRock, Inc. | 0.00% | No change | 113 | $247 |
| US Bancorp \de | 0.00% | No change | 25 | $55 |
| Bank of America Corp. | 0.00% | Add +25.0% | 15 | $32 |
| Allworth Financial LP | 0.00% | No change | 3 | $12 |
| Morgan Stanley | 0.00% | No change | 4 | $9 |
| Danske Bank A/S | 0.00% | No change | 1 | $2 |
"% of holder's portfolio" is SNOA's weight in each manager's 13F, not the share of Sonoma Pharmaceuticals Inc. the manager owns.